» Articles » PMID: 7327068

Therapy of Experimental Tuberculosis in Guinea Pigs with Mycobacterial Phages DS-6A, GR-21 T, My-327

Overview
Journal Czech Med
Specialty General Medicine
Date 1981 Jan 1
PMID 7327068
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Guinea pigs, weighing 250-350 g, were infected with approximately 5,000 of live germs M- tuberculosis H 37 Rv grown 10 days in deep culture of liquid semisynthetic medium according to Sula. The infection was performed subcutaneously in inquinal region. For the therapy following phages were used: DS-6A, GR-21/T, My-327 injected twice a week subcutaneously in the dose of 10(6)/1 ml of live particles for 10 weeks. The therapeutic effect was expressed by spleen and hilus index. Out of the phages used, phage DS-6A had the highest therapeutic effect with mean spleen index of 0.19, corresponding approximately to the spleen index reached with the most effective tuberculostaticum INH. The exact explanation of the phage therapeutic effect in given experimental conditions, when the phages are not applied locally in order to gain the direct contact with infectious antigens, is not known. It is suggested that there presumably exists an interaction between the released phage nucleic acid and the nucleic acid synthesis needed for the growth of mycobacteria in vivo.

Citing Articles

Rv2617c is involved in stress response and phage infection resistance.

Moukendza Koundi L, Ekomi Moure U, Boni F, Hamdi I, Fan L, Xie J Heliyon. 2024; 10(5):e27400.

PMID: 38495141 PMC: 10943396. DOI: 10.1016/j.heliyon.2024.e27400.


Bacteriophage therapy for the treatment of Mycobacterium tuberculosis infections in humanized mice.

Yang F, Labani-Motlagh A, Bohorquez J, Moreira J, Ansari D, Patel S Commun Biol. 2024; 7(1):294.

PMID: 38461214 PMC: 10924958. DOI: 10.1038/s42003-024-06006-x.


Mycobacteriophages in diagnosis and alternative treatment of mycobacterial infections.

Ouyang X, Li X, Song J, Wang H, Wang S, Fang R Front Microbiol. 2023; 14:1277178.

PMID: 37840750 PMC: 10568470. DOI: 10.3389/fmicb.2023.1277178.


Bacteriophages of Mycobacterium tuberculosis, their diversity, and potential therapeutic uses: a review.

Kelishomi F, Khanjani S, Fardsanei F, Saghi Sarabi H, Nikkhahi F, Dehghani B BMC Infect Dis. 2022; 22(1):957.

PMID: 36550444 PMC: 9773572. DOI: 10.1186/s12879-022-07944-9.


A Review on Mycobacteriophages: From Classification to Applications.

Hosseiniporgham S, Sechi L Pathogens. 2022; 11(7).

PMID: 35890022 PMC: 9317374. DOI: 10.3390/pathogens11070777.